Dr. Cohen and colleagues’ study was funded by the Municipal Health Authority and Marcia Maria Braido Hospital in São Paulo, Brazil. Dr. Cohen disclosed that he received previous study funding from Covidien, and one of his coauthors, Dr. David E. Cummings of the University of Washington, Seattle, disclosed receiving past funding from Ethicon Endo-Surgery. The other authors said they had no relevant financial disclosures.
News
Gastric Bypass Induces Diabetes Remission in Mildly Obese
More Obesity News
- Triple-agonist retatrutide hits new weight loss highs
- Half of teens drop below obesity cutoff with semaglutide
- Obesity drug with swallowable balloon boosts weight loss
- How BMI over time impacts GI cancer risk
- Endoscopic sleeve gastroplasty plus obesity drugs add up to more weight loss
- Bariatric surgery cuts risk for obesity-related cancers in half: Study
- Optimal time period for weight loss drugs: Debate continues
- Should GI own the obesity field?
Question 1 of 4